Stay updated on Safety of ION464 in Multiple System Atrophy Clinical Trial
Sign up to get notified when there's something new on the Safety of ION464 in Multiple System Atrophy Clinical Trial page.

Latest updates to the Safety of ION464 in Multiple System Atrophy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision tag, v3.6.4, was added to the page and the previous v3.6.3 tag was removed, reflecting a minor site version update.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision tag changed from v3.6.2 to v3.6.3, indicating a new release of the page. This is a metadata update rather than a change to the study content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a site or template deployment; no study data or visible content changes are indicated by this update.SummaryDifference0.0%

- Check54 days agoChange DetectedDirect links to key sections such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study were added to the page navigation. The Intervention/Treatment header formatting was standardized and the site revision updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check61 days agoChange DetectedThe footer revision label changed from v3.5.4 to v3.5.5, reflecting a minor page revision that updates metadata rather than core content.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry v3.5.4 was added to the page, replacing the previous v3.5.3. This reflects a minor site update to the page's revision history rather than a change to study information.SummaryDifference0.1%

Stay in the know with updates to Safety of ION464 in Multiple System Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ION464 in Multiple System Atrophy Clinical Trial page.